Silverscript Insurance Company
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
TESTIMONY of CRAIG L. GARTHWAITE, Ph.D. Associate
TESTIMONY OF CRAIG L. GARTHWAITE, Ph.D. Associate Professor of Strategy Herman Smith Research Professor in Hospital and Health Services Management Director of Health Enterprise Management Program (HEMA) Kellogg School of Management Northwestern University Before the House Judiciary Committee Subcommittee on Regulatory Reform, Commercial and Antitrust Law On “Competition in the Pharmaceutical Supply Chain: The Proposed Merger of CVS Health and Aetna” February 27, 2018 1 SUMMARY OF STATEMENT • I am here today to discuss the potential economic implications and rationales for the proposed merger of CVS Health and Aetna. This merger will combine the assets of a pharmacy benefit manager, health insurer, chain of retail pharmacies, chain of minute clinics, and a variety of other assets into a single firm. • CVS-Aetna is a vertical merger. i.e. firms at the same stage of the value chain that are proposing to combine into a single entity. Unlike horizontal mergers (i.e. firms at the same stage of the value chain merging such as the recently opposed Anthem-Cigna and Aetna-Humana merger) the theory and the empirical evidence regarding the impacts of vertical mergers on social welfare is relatively ambiguous. • Vertically integrating firms choose to avoid the market in favor using an internal supplier (this is often referred to colloquially as a “make or buy” decision for the firm). This decision is often met with skepticism by economists and strategy professionals. This skepticism arises from the fact that a well-functioning economic market is efficient in that it provides the appropriate incentives for a good or service of a particularly quality to be produced by the lowest cost firm at the lowest possible price. -
ANNUAL REPORT PURSUANT to SECTION 13 OR 15(D)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to_________ Commission file number: 001-01011 CVS HEALTH CORPORATION (Exact name of registrant as specified in its charter) Delaware 05-0494040 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) One CVS Drive, Woonsocket, Rhode Island 02895 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (401) 765-1500 Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $0.01 per share CVS New York Stock Exchange Securities registered pursuant to Section 12(g) of the Act: None Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☑ Yes ☐ No Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☑ No Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. -
96377 Coventry Health Care of Missouri, Inc. Original Filing March
ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Missouri, Inc. ASSETS Current Year Prior Year 1 2 3 4 Net Admitted Assets Net Admitted Assets Nonadmitted Assets (Cols. 1 - 2) Assets 1. Bonds (Schedule D) 217,332,389 0 217,332,389 175,371,988 2. Stocks (Schedule D): 2.1 Preferred stocks 0 0 0 0 2.2 Common stocks 0 0 0 0 3. Mortgage loans on real estate (Schedule B): 3.1 First liens 5,188,518 0 5,188,518 5,741,230 3.2 Other than first liens 0 0 0 0 4. Real estate (Schedule A): 4.1 Properties occupied by the company (less $ 0 encumbrances) 0 0 0 0 4.2 Properties held for the production of income (less $ 0 encumbrances) 0 0 0 0 4.3 Properties held for sale (less $ 0 encumbrances) 0 0 0 0 5. Cash ($ 39,080,724 , Schedule E - Part 1), cash equivalents ($ 30,338,817 , Schedule E - Part 2) and short-term investments ($ 0 , Schedule DA) 69,419,541 0 69,419,541 34,597,753 6. Contract loans, (including $ 0 premium notes) 0 0 0 0 7. Derivatives (Schedule DB) 0 0 0 0 8. Other invested assets (Schedule BA) 1,797,845 0 1,797,845 1,548,285 9. Receivables for securities 0 0 0 0 10. Securities lending reinvested collateral assets (Schedule DL) 0 0 0 0 11. Aggregate write-ins for invested assets 0 0 0 0 12. Subtotals, cash and invested assets (Lines 1 to 11) 293,738,293 0 293,738,293 217,259,256 13. -
95489 COVENTRY HEALTH CARE of KANSAS, INC. Original Filing
ANNUAL STATEMENT FOR THE YEAR 2018 OF THE COVENTRY HEALTH CARE OF KANSAS, INC. ANNUAL STATEMENT FOR THE YEAR 2018 OF THE COVENTRY HEALTH CARE OF KANSAS, INC. EXHIBIT 2 - ACCIDENT AND HEALTH PREMIUMS DUE AND UNPAID 1 2 3 4 5 6 7 Name of Debtor 1 - 30 Days 31 - 60 Days 61 - 90 Days Over 90 Days Nonadmitted Admitted 0199999 Total individuals 34,526 34,526 Group Subscribers: 0299998. Premiums due and unpaid not individually listed 31,864 (2,546) (2,322) 590 26,406 0299999. Total group 31,864 (2,546) (2,322) 0 590 26,406 0399999. Premiums due and unpaid from Medicare entities 0499999. Premiums due and unpaid from Medicaid entities 18 0599999 Accident and health premiums due and unpaid (Page 2, Line 15) 31,864 (2,546) (2,322) 34,526 35,116 26,406 ANNUAL STATEMENT FOR THE YEAR 2018 OF THE COVENTRY HEALTH CARE OF KANSAS, INC. Exhibit 3 - Health Care Receivables N O N E Exhibit 3A - Health Care Receivables Collected and Accrued N O N E 19, 20 ANNUAL STATEMENT FOR THE YEAR 2018 OF THE COVENTRY HEALTH CARE OF KANSAS, INC. EXHIBIT 4 - CLAIMS UNPAID AND INCENTIVE POOL, WITHHOLD AND BONUS (Reported and Unreported) Aging Analysis of Unpaid Claims 1 2 3 4 5 6 7 Account 1 - 30 Days 31 - 60 Days 61 - 90 Days 91 - 120 Days Over 120 Days Total Claims Unpaid (Reported) 0199999. Individually listed claims unpaid 0 0 0 0 0 0 0299999. Aggregate accounts not individually listed- uncovered 24,951 0 0 0 0 24,951 0399999. -
Health Is Personal
Health is personal. 2020 Annual Report Dear Fellow Stockholders: In my first letter as president and chief executive officer, let me begin by expressing how honored I am to lead this great company and our dedicated team of nearly 300,000 CVS Health colleagues as we work together to reimagine health care. During one of the most challenging years in our nation’s history, our purpose to help people on their path to better health has never been more important. Since the pandemic struck, CVS Health colleagues served a prominent role in supporting our customers, providers, and communities, while we outperformed on our financial commitments. Over the past decade, we have been on a journey to become the nation’s leading diversified health services company. As one of the most trusted brands in America, our presence in communities across the country allows us to meet consumers where they are and support them for every Karen S. Lynch meaningful moment of health throughout their lifetime. President and Chief Executive Officer Continued growth in our core subscription customers, achieving for the Federal Pharmacy Partnership businesses drove our strong high customer satisfaction results. program through which we administer performance in 2020 COVID-19 immunizations in our In 2020, CVS Health year-over-year Delivered new solutions and CVS Pharmacy locations. With the total revenues grew by 5 percent to established an unparalleled response commitment and hard work of our $268.7 billion. GAAP diluted earnings to COVID-19 employees, we have the capacity to per share (EPS) from continuing During the past year, we delivered new administer 20 to 25 million doses operations grew by 8 percent to $5.47 market solutions and strengthened our per month, depending on availability. -
95489 Coventry Health Care of Kansas, Inc. Original Filing Quarter
STATEMENT AS OF MARCH 31, 2021 OF THE Coventry Health Care of Kansas, Inc. ASSETS Current Statement Date 4 1 2 3 December 31 Net Admitted Assets Prior Year Net Assets Nonadmitted Assets (Cols. 1 - 2) Admitted Assets 1. Bonds 11,977,095 0 11,977,095 12,067,386 2. Stocks: 2.1 Preferred stocks 0 0 0 0 2.2 Common stocks 0 0 0 0 3. Mortgage loans on real estate: 3.1 First liens 0 0 0 0 3.2 Other than first liens 0 0 0 0 4. Real estate: 4.1 Properties occupied by the company (less $ 0 encumbrances) 0 0 0 0 4.2 Properties held for the production of income (less $ 0 encumbrances) 0 0 0 0 4.3 Properties held for sale (less $ 0 encumbrances) 0 0 0 0 5. Cash ($ 14,196,183 ), cash equivalents ($ 12,590,597 ) and short-term investments ($ 0 ) 26,786,780 0 26,786,780 24,818,610 6. Contract loans (including $ 0 premium notes) 0 0 0 0 7. Derivatives 0 0 0 0 8. Other invested assets 0 0 0 0 9. Receivables for securities 0 0 0 0 10. Securities lending reinvested collateral assets 0 0 0 0 11. Aggregate write-ins for invested assets 0 0 0 0 12. Subtotals, cash and invested assets (Lines 1 to 11) 38,763,875 0 38,763,875 36,885,996 13. Title plants less $ 0 charged off (for Title insurers only) 0 0 0 0 14. Investment income due and accrued 70,910 0 70,910 71,505 15. -
95517 Aetna Health Inc. (A Maine Corporation) Original Filing March
ANNUAL STATEMENT FOR THE YEAR 2018 OF THE Aetna Health Inc. (a Maine corporation) ANNUAL STATEMENT FOR THE YEAR 2018 OF THE Aetna Health Inc. (a Maine corporation) ASSETS Current Year Prior Year 1 2 3 4 Net Admitted Assets Net Admitted Assets Nonadmitted Assets (Cols. 1 - 2) Assets 1. Bonds (Schedule D) 27,575,449 27,575,449 24,939,445 2. Stocks (Schedule D): 2.1 Preferred stocks 0 0 2.2 Common stocks 0 0 3. Mortgage loans on real estate (Schedule B): 3.1 First liens 0 3.2 Other than first liens 0 4. Real estate (Schedule A): 4.1 Properties occupied by the company (less $ encumbrances) 0 4.2 Properties held for the production of income (less $ encumbrances) 0 4.3 Properties held for sale (less $ encumbrances) 0 5. Cash ($ 0 , Schedule E - Part 1), cash equivalents ($ 5,677,469 , Schedule E - Part 2) and short-term investments ($ 0 , Schedule DA) 5,677,469 5,677,469 18,485 6. Contract loans, (including $ premium notes) 0 7. Derivatives (Schedule DB) 0 0 8. Other invested assets (Schedule BA) 0 0 0 9. Receivables for securities 0 10. Securities lending reinvested collateral assets (Schedule DL) 0 0 11. Aggregate write-ins for invested assets 0 0 0 0 12. Subtotals, cash and invested assets (Lines 1 to 11) 33,252,918 0 33,252,918 24,957,930 13. Title plants less $ charged off (for Title insurers only) 0 14. Investment income due and accrued 153,609 0 153,609 102,837 15. Premiums and considerations: 15.1 Uncollected premiums and agents' balances in the course of collection 2,411,055 126,069 2,284,986 2,190,164 15.2 Deferred premiums and agents' balances and installments booked but deferred and not yet due (including $ earned but unbilled premiums) 0 15.3 Accrued retrospective premiums ($ 154 ) and contracts subject to redetermination ($ ) 154 0 154 502,677 16. -
95489 Coventry Health Care of Kansas, Inc. Original Filing March
ANNUAL STATEMENT FOR THE YEAR 2020 OF THE Coventry Health Care of Kansas, Inc. ASSETS Current Year Prior Year 1 2 3 4 Net Admitted Assets Net Admitted Assets Nonadmitted Assets (Cols. 1 - 2) Assets 1. Bonds (Schedule D) 12,067,386 0 12,067,386 10,401,827 2. Stocks (Schedule D): 2.1 Preferred stocks 0 0 0 0 2.2 Common stocks 0 0 0 0 3. Mortgage loans on real estate (Schedule B): 3.1 First liens 0 0 0 0 3.2 Other than first liens 0 0 0 0 4. Real estate (Schedule A): 4.1 Properties occupied by the company (less $ 0 encumbrances) 0 0 0 0 4.2 Properties held for the production of income (less $ 0 encumbrances) 0 0 0 0 4.3 Properties held for sale (less $ 0 encumbrances) 0 0 0 0 5. Cash ($ 16,309,983 , Schedule E - Part 1), cash equivalents ($ 8,508,627 , Schedule E - Part 2) and short-term investments ($ 0 , Schedule DA) 24,818,610 0 24,818,610 7,996,467 6. Contract loans, (including $ 0 premium notes) 0 0 0 0 7. Derivatives (Schedule DB) 0 0 0 0 8. Other invested assets (Schedule BA) 0 0 0 0 9. Receivables for securities 0 0 0 0 10. Securities lending reinvested collateral assets (Schedule DL) 0 0 0 0 11. Aggregate write-ins for invested assets 0 0 0 0 12. Subtotals, cash and invested assets (Lines 1 to 11) 36,885,996 0 36,885,996 18,398,294 13. Title plants less $ 0 charged off (for Title insurers only) 0 0 0 0 14.